Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Liver damage caused by adelphan]

R Enat, G Rader, D Barzilai

Schweizerische Medizinische Wochenschrift

|May 14, 1977

Summary

This summary is machine-generated.

Adelphan, a medication containing Rauwolfia alkaloids and dihydrazinophthalazine, can cause fever, chills, and liver damage. This case report adds Adelphan to the list of drugs known to induce hepatic injury.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Atopic dermatitis management: comparing the treatment patterns of dermatologists in Japan, U.S.A. and U.K.

The British journal of dermatology·2002

Same author

Efficacy of sunscreen in preventing nevi.

JAMA·2001

Same author

[Superficial skin necrosis--an uncommon manifestation of short bowel syndrome].

Harefuah·2000

Same author

Conventional medical care and unconventional therapies.

JAMA·2000

Same author

A pilot study on the hemodynamic effect of short-term ursodeoxycholic acid therapy in patients with stable liver cirrhosis.

The American journal of gastroenterology·1999

Same author

Low-dose vasopressin restores diuresis both in patients with hepatorenal syndrome and in anuric patients with end-stage heart failure.

Journal of internal medicine·1999

Same journal

Respiratory function test in the case of temporary phrenic nerve contusion, associated with pneumoperitoneum; About the diagnostic value of laparoscopy.

Schweizerische medizinische Wochenschrift·2010

Same journal

Treatment of pulmonary tuberculosis and pleurisy by means of temporary paralysis of the diaphragm, supported by the pneumoperitoneum.

Schweizerische medizinische Wochenschrift·2010

Same journal

Boeck's disease as a tuberculous syndrome.

Schweizerische medizinische Wochenschrift·2010

Same journal

Enteral primary tubercular complexes

Schweizerische medizinische Wochenschrift·2010

Same journal

Tuberculous stenoses of the large bronchi.

Schweizerische medizinische Wochenschrift·2010

Same journal

About the enzyme action.

Schweizerische medizinische Wochenschrift·2010

See all related articles

Area of Science:

Pharmacology
Hepatology
Internal Medicine

Background:

Adelphan, a combination drug, comprises Rauwolfia alkaloids (Reserpin) and 1,4-dihydrazinophthalazine (Nepresol).
Previous literature has not documented hepatic damage associated with Adelphan or its individual components.

Observation:

A patient presented with recurrent episodes of fever, chills, and elevated liver enzymes.
These symptoms consistently occurred following the administration of Adelphan.
The patient's clinical presentation suggested a drug-induced hepatotoxicity.

Findings:

The patient experienced significant hepatic damage, evidenced by clinical symptoms and laboratory findings.
The adverse reactions were temporally associated with Adelphan intake.

Related Experiment Videos

Exclusion of other potential causes of liver injury was considered.

Implications:

Adelphan should be recognized as a potential cause of drug-induced liver injury.
Clinicians should consider Adelphan in the differential diagnosis of unexplained hepatic damage.
Further investigation into the hepatotoxic mechanisms of Adelphan's components may be warranted.